Butterworth Laboratories Expands UK Lab Operations
PTSM: Pharmaceutical Technology Sourcing and Management
The company has secured an additional facility in Hampton, Middlesex, as part of a project to expand its UK-based operations by 15% in 2017.
Butterworth Laboratories, a provider of analytical services, announced on March 27, 2017 that it has secured an additional facility in Hampton, Middlesex, as part of a project to expand its laboratory operations by 15% in the United Kingdom in 2017. This expansion is the first phase of a longer term plan to deliver increased capacity of 60% by 2020. Butterworth Labs is expecting strong growth and says that the move will secure the Teddington facility as the UK laboratory operations, while providing the platform for continued growth in key areas.
The expansion coincides with the appointment of David Hawkins as managing director. Hawkins was formerly the company's chief operating officer. Doris Butterworth continues on the board as chairman along with finance director John Gearey and newly appointed non-executive director Patrick Stewart.
Source: Butterworth Laboratories
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
